EODData

MEMBERSHIP REGISTER LOG IN

PAR, BIM: Biomerieux SA

04 Sep 2025
LAST:

115.7

CHANGE:
 2.20		OPEN:
117.0		HIGH:
119.8		ASK:
115.8		VOLUME:
182.6K
CHG(%):
1.87		PREV:
117.9		LOW:
113.4		BID:
114.0		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
04 Sep 25117.0119.8113.4115.7182.6K
03 Sep 25116.8118.0116.6117.9135.8K
02 Sep 25117.6117.8115.6115.8105.7K
01 Sep 25118.7119.1117.6117.971.6K
29 Aug 25117.9119.7117.9118.775.2K
28 Aug 25119.0119.2117.6117.869.1K
27 Aug 25119.0119.6118.0119.064.9K
26 Aug 25119.5124.3117.7119.4398.7K
25 Aug 25127.1127.1125.9126.142.5K
22 Aug 25127.4127.7126.3127.467.6K

COMPANY PROFILE

Name:Biomerieux SA
About:bioMérieux S.A. develops and markets in vitro diagnostic solutions for infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It offers CHROMID RANGE, a chromogen culture media; RAPIDEC CARBA NP biochemical test for the detection of carbapenemase producing bacteria; air, surface, and water monitoring systems; BACT/ALERT VIRTUO or 3D, a blood sample culture system; BIOFIRE, a multiplex polymerase chain reaction system; BIOFIRE SPOTFIRE Lowplex PCR point-of-care system; VITEK MS, a mass spectrometry system; VITEK 2, an automated identification and antimicrobial susceptibility testing system; API RANGE standardized ID strips; VITEK REVEAL Rapid AST system; ETEST gradient method on culture media; BIOMERIEUX EPISEQ CS whole genome sequencing solution for epidemiologic monitoring; and VIDAS, a specific marker of severe bacterial infections/sepsis. It also develops Biomérieux vision suite, a software that provides information to support diagnosis and clinical decision making; culture media and associated instruments; ARGENE that provides PCR tests for diagnosing viral respiratory diseases; EMAG system and NUCLISENS extraction reagents for DNA and RNA extraction; GENE-UP and VERIFLOW for detection of microorganisms for the food industry; ETEST for manual measurement of minimum inhibitory concentration; API and RAPIDEC CARBA NP for identification of bacteria and manual antimicrobial susceptibility testing; BIOBALL for quantitative microbiological quality control; CHEMUNEX, a microbiology instrument; ENDONEXT for detection of endotoxins; TEMPO for fluorescence counting of bacteria; and Hybiome, a CLIA technology, as well as lab consultancy service and training modules. It has partnership with Boehringer Ingelheim and Evotec. bioMérieux S.A. was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy-l'Étoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.
Sector:Healthcare
Address:376 Chemin De l?Orme, Marcy-l'Étoile, France, 69280
Website:https://www.biomerieux.com
ISIN:FR0013280286
LEI:549300AK8Y0LBIQ4T071

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

P/E Ratio:32.45
EPS Ratio:3.64
DivYield:0.01
Div/Share:0.90
Price to Book:3.31
Price to Sales:3.74
EBITDA:948.2M
Shares:117.93M
Market Cap:13.644B

TECHNICAL INDICATORS

MA5:117.20
MA10:119.57
MA20:122.93
MA50:121.84
MA100:120.41
MA200:117.26
RSI14:26.39
WPR14:-100.00
MTM14:-11.50
ROC14:-0.09
ATR:2.48
Week High:119.80
Week Low:113.40
Month High:128.30
Month Low:113.40
Year High:128.30
Year Low:95.90

RECENT DIVIDENDS

Date Amount
09 Jun 2025$0.90
07 Jun 2024$0.85
06 Jun 2023$0.85
06 Jun 2022$0.85
04 Jun 2021$0.62
14 Jul 2020$0.19
04 Jun 2019$0.35
05 Jun 2018$0.34
06 Jun 2017$0.11
07 Jun 2016$0.11